IL31 and Alzheimer disease: Previous research of our group has shown that addressing the varied levels of relevant cytokines of the disease, including IL-13, IL-31 and IL-9, produced by CLA+ memory T cells in an ex vivo model of AD, is essential for stratifying patients based on clinical features like disease severity and pruritus (19–21).